Adding new experimental arms to randomised clinical trials: Impact on error rates

BACKGROUND: Experimental treatments pass through various stages of development. If a treatment passes through early-phase experiments, the investigators may want to assess it in a late-phase randomised controlled trial. An efficient way to do this is adding it as a new research arm to an ongoing tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Choodari-Oskooei, Babak, Bratton, Daniel J, Gannon, Melissa R, Meade, Angela M, Sydes, Matthew R, Parmar, Mahesh KB
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263043/
https://www.ncbi.nlm.nih.gov/pubmed/32063029
http://dx.doi.org/10.1177/1740774520904346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263043/
https://www.ncbi.nlm.nih.gov/pubmed/32063029
http://dx.doi.org/10.1177/1740774520904346

Ejemplares similares